The Laverty Pathology 12th Annual Women’s Health Conference will be held this year on Saturday 15 March 2014 at the University of New South Wales
Click here to download the Invitation.
Click here to download the Registration Form.
The Laverty Pathology 12th Annual Women’s Health Conference will be held this year on Saturday 15 March 2014 at the University of New South Wales
Click here to download the Invitation.
Click here to download the Registration Form.
Ian Kadish, CEO, Laverty Pathology presented on “Private Pathology Overview” at the National Pathology Forum 2013.
Click HERE to download a PDF copy of the presentation.
Also feel free to view the presentation by Ian Kasish HERE.
This annual conference provides a platform for the public and private sectors to come together and discuss all the latest issues affecting the pathology sector in Australia.
For more information, please visit the conference website: http://www.informa.com.au/pathologyforum
We would like to make you aware of an important initiative that has just launched to improve the AWARENESS of the VALUE of PATHOLOGY.
As you may be aware, pathology is poorly understood by the general public, by government and by other important stakeholders. Most Australians are not aware of the role and importance of pathology in almost every important medical diagnosis. Few are aware that pathology provides the linchpin information for more than 70% of all medical decisions!
Whilst this lack of understanding continues, the vitally important role that each of us plays in enhancing the health of Australians will continue unappreciated and unrecognised.
The consequences of this lack of understanding as to the important role that we all play in maintaining the health of our fellow Australians – is that the Government entities, insurance companies and others continually reduce the resources and funding for the work that we do – in patient care, in teaching and training, in the cities and in the country, for both public and private patients.
For the first time ever, the industry has come together to form an industry-wide entity, called “Know Pathology”, that has the sole aim of raising awareness among all Australians of the critical value that our specialist Pathologists, PhDs, Scientists, Collectors, Technical Officers and support staff play in ensuring that Australia maintains a health system in general, and a pathology system in particular, that is the envy of the world.
This industry entity is non-partisan and comprises all pathology industry participants including the College of Pathologists, pathology suppliers, the public pathology sector and each of the major private pathology sector participants.
It is important that each and every one of us takes the time and effort to register our support for this “Know Pathology” campaign. It is vitally important that we ensure that Australia’s high quality, highly effective and efficient pathology service is maintained for all Australians.
Please go to the link http://knowpathology.com.au/ and complete the section to Register your Support by completing your name, address and email account…see snapshot of the relevant section to be completed on the website below:

It is important that we do this, not only in our interest, but also in the interests of the patients that we serve.
Laverty Pathology are pleased to offer women access to an exciting innovation in pregnancy care. The iGeneScreen™ Non-Invasive Foetal Screening test is now availabe.

To download a patient information brochure click here.
Click here to download an iGeneScreen™ Doctor Information Sheet
Click here to download an iGeneScreen™ Request and Informed Consent Form.
If you would like to be added to the list of Doctors providing this test through Laverty Pathology, please email our marketing department by clicking here and provide us with your name, practice name, address and phone number and we will include you on the next list update.
iGeneScreen™ is an INEX trademark for the non-invasive prenatal screening test developed by BGI.
Innovations Exchange (INEX) is a leading women’s health molecular diagnostic company focused on the research and development of innovative technology for the advancement of women’s, maternal and fetal health. http://www.inex.sg/
BGI is the world’s largest sequencing and bioinformatics institute for the advancement of genomics research and technology. www.genomics.cn/en
Accurate measurement of ventilatory function is now more accessible.
Measurement of ventilatory function is part of routine assessment of respiratory disease. Spirometry is the lung function test of choice for both diagnosis and serial assessment of obstructive airways disease.
The aim of spirometry in general practice is to assess variability of airflow obstruction, and to measure the degree of airflow obstruction compared with predicted normal values.
Current clinical practice guidelines recommend that all doctors managing asthma and COPD should have access to and use a spirometer for optimal assessment of lung function.
Most adults and children over 7 years of age can perform spirometry.
At Laverty Pathology, we offer accurate spirometry conforming to international standards, performed by experienced technicians, and reported by specialist physicians.
Download Laverty Pathology’s newsletter by clicking this link: Spirometry testing at Laverty Pathology
Ed Bateman wants to give money away while he can still enjoy the process of giving.
The managing director of $2.5 billion listed medical services business Primary Health Care Ed Bateman has informed the market this morning of his plans to give away a large part of his holding in the company, worth about $85 million.
Bateman’s wealth has risen strongly over the past 12 months. In May last year, he had an estimated net worth of $420 million. This has since risen to about $500 million on the back of strong growth of the Primary Health Care share price.
Bateman wrote that he and his wife, Belinda Bateman, wanted the beneficiaries to “receive these gifts now when they are likely to be of most use and when Dr and Mrs Bateman can enjoy the process of making these gifts”.
He also said that the gifts do not impact on his ongoing commitment to his role as managing director.
Bateman is the second largest shareholder in Primary Health Care. He has 37.2 million shares, which equates to 7.4 per cent of the listed capital.
In this morning’s announcement, Bateman said that after the gifts are made he will retain about 20 million shares.
The split between family and charity is unknown.
Strong performance by the company’s imaging business has helped push up earnings.
Primary Health Care reported earnings before tax, depreciation and amortisation of $350 million last year. Its half-ear results suggest the company is on track to achieve its target of $370 million to $380 million this year.
Speaking exclusively to Laverty Pathology this week, Dr Curtis Parvin of Bio-Rad’s Advanced Statistical Research Division discussed “Patient Risk in Quality Control Design”.
This talk complements Laverty’s ongoing professional development of staff and enables the laboratory to identify patient risk implications within it’s operation.
To download your copy of the presentation just click the link below:
Parvin_QC&PatientRisk_Laverty_Sydney_2012
Take a look at some of the photos from the conference
Wednesday 14th November 2012
Park Hyatt Sydney 7 Hickson Road
The Rocks, Sydney NSW
Please download and complete the registration form below and return to our Medical Liasion Team by fax: (02) 9005 7815.
Womens Health Update & Review- Invitation
RSVP BY 9th November 2012
Please contact Amy Phillips on (02) 9005 7107 or email marketing@laverty.com.au for further details.
Women’s Health Conference
We are pleased to invite you to our 11th Annual Womens Health Conference for General Practitioners on Saturday 13th October 2012 in ‘The Scientia Building’, University of New South Wales, Barker St, Randwick.
Please click on the following links for more information and registration.